OAKLAND, Calif.--(BUSINESS WIRE)--Eko today announced Eko Telehealth, the first and only AI-powered telehealth platform for virtual cardiac and pulmonary monitoring. Being used by more than 200 health systems today, Eko Telehealth incorporates stethoscope and ECG live-streaming combined with embedded video conferencing and FDA-cleared AI algorithms for heart murmur and AFib detection.
“Eko dramatically increased our ability to scale up and care for COVID-possible and COVID-positive patients. It allowed for rapid integration which immediately minimized potential exposures, decreased personal protective equipment usage and increased physician efficiencies involving virtual patient assessments and ongoing observation”
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
“Video telemedicine and virtual patient visits only go so far. Patients with complex cardiovascular diseases will receive incomplete care through just video conference. It’s critical that a provider is able to assess a patient’s heart and lung function remotely,” said Connor Landgraf, CEO and co-founder of Eko. “The Eko intelligent telehealth platform gives providers the most comprehensive picture of a patient’s heart and lung health. Virtual cardiac and pulmonary medicine will become the standard of care even after the pandemic abates.”
Eko Telehealth delivers:
AI-powered and FDA-cleared identification of heart murmurs and atrial fibrillation (AFib), assisting providers in the detection and monitoring of heart disease during virtual visits
Lung and heart sound live-streaming for a thorough virtual examination
Single-lead ECG live-streaming, enabling providers to assess for rhythm abnormalities
Embedded HIPAA-compliant video conferencing, or can work alongside the video conferencing platform a health system has in place
Symptoms of valvular heart disease and AFib often go undiagnosed during routine physical exams. With the development of Eko’s AI screening algorithms, clinicians are able to harness state-of-the-art machine learning to detect heart disease at the earliest point of care regardless if the patient visit is in-person or remote.
With Eko, a provider at a patient site, such as a hospital, rural clinic or nursing home can stream stethoscope audio and ECG to a physician residing in a separate room or at a virtual care center, medical center or specialty clinic, thus reducing in-person exposure to infectious diseases, like COVID-19.
“Eko dramatically increased our ability to scale up and care for COVID-possible and COVID-positive patients. It allowed for rapid integration which immediately minimized potential exposures, decreased personal protective equipment usage and increased physician efficiencies involving virtual patient assessments and ongoing observation,” said Craig Davis, MD, Southern Illinois Healthcare.